Modelling Scientist Opportunity at Novo Nordisk A/S
About the department
The Quantitative Clinical Pharmacology (QCP) department supports the entire
Novo Nordisk development portfolio with model-based analyses from first in
human trials to registration. We are a team of dedicated modelling scientists
with an important role in the development of new drugs at Novo Nordisk as
responsible for designing, analysing, interpreting, communicating and reporting
quantitative clinical pharmacology information at all stages of clinical drug
development.
The job
As Modelling Scientist you will have an important role in the development of
new drugs at Novo Nordisk. You will be part of multidisciplinary project teams
where you will be responsible for developing modelling analysis plans for the
project and follow them to completion. The position is located in Søborg,
Denmark
Qualifications
You hold a university degree, e.g. statistics, engineering, pharmacy or other,
preferably complemented by a PhD. You must have in depth understanding of
pharmacokinetics/pharmacodynamics, statistical methodology, and data
interpretation as well as hands-on experience performing model-based analyses
using S-PLUS/R and/or NONMEM. You are innovative with a high degree of
independence, result and quality oriented, and thrive in a continuously
changing environment with tight deadlines. You appreciate an informal
atmosphere and act as a dedicated team player. As your colleagues will have
different academic backgrounds, good presentation, communication and
negotiation skills are essential. You are fluent in English both orally and
written.
At Novo Nordisk you will work with specialists from around the world. Our
ambitious teams work toward developing the next generation of care. As a
growing organisation, we offer unique possibilities for personal and
professional development, as well as a chance to work alongside the best in the
field.
Contact
For further information, please contact Henrik Agersø at +45 3079 3522
Apply at:
http://www.novonordisk.com/careers/job_section/jp.asp?jobid=26999BR&joblng=uk&jobcnt=Denmark&type=1a
Deadline
31 January 2015.
_____________________________________________________________________________
Henrik Agersø, DVM, PhD
Director and Head of Quantitative Clinical Pharmacology
Global Development
Novo Nordisk A/S
Vandtårnsvej 108-110
DK-2860 Søborg
Denmark
+45 4444 8888 (phone)
+45 3079 3522 (mobile)
[email protected]
http://www.novonordisk.com
http://www.facebook.com/novonordisk |
http://www.twitter.com/novonordisk |
http://www.linkedin.com/company/novo-nordisk |
http://www.Youtube.com/novonordisk |
http://www.pinterest.com/novonordisk
Changing the way we look at diabetes
A new DAWN for people with diabetes? Click here to read
http://www.dawnstudy.com/
This e-mail (including any attachments) is intended for the addressee(s) stated
above only and may contain confidential information protected by law. You are
hereby notified that any unauthorized reading, disclosure, copying or
distribution of this e-mail or use of information contained herein is strictly
prohibited and may violate rights to proprietary information. If you are not an
intended recipient, please return this e-mail to the sender and delete it
immediately hereafter. Thank you.